LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.58 | 84.90 | 65 | 663 | 0.0980 | -0.0861 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.58 | 84.90 | 1133 | 663 | 1.7079 | 1.3955 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.29 | 84.90 | 338 | 766 | 0.4408 | 0.5452 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.29 | 84.90 | 1151 | 766 | 1.5009 | 1.2729 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.29 | 84.90 | 151 | 766 | 0.1969 | 0.1988 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.29 | 84.90 | 1226 | 766 | 1.5987 | 1.3185 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 17.99 | 84.90 | 464 | 898 | 0.5161 | 0.6469 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 17.99 | 84.90 | 1241 | 898 | 1.3805 | 1.1987 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 17.99 | 84.90 | 227 | 898 | 0.2525 | 0.3349 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 17.99 | 84.90 | 1305 | 898 | 1.4517 | 1.2314 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 19.69 | 84.90 | 960 | 1239 | 0.7746 | 0.8722 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 19.69 | 84.90 | 1354 | 1239 | 1.0924 | 1.0462 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 19.69 | 84.90 | 804 | 1239 | 0.6487 | 0.7883 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 19.69 | 84.90 | 1483 | 1239 | 1.1965 | 1.0950 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.40 | 84.90 | 1352 | 1454 | 0.9294 | 0.9646 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.40 | 84.90 | 1527 | 1454 | 1.0497 | 1.0238 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.40 | 84.90 | 1301 | 1454 | 0.8944 | 0.9463 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 21.40 | 84.90 | 1602 | 1454 | 1.1013 | 1.0476 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.10 | 84.90 | 1514 | 1616 | 0.9368 | 0.9695 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.10 | 84.90 | 1667 | 1616 | 1.0314 | 1.0146 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.10 | 84.90 | 1619 | 1616 | 1.0017 | 1.0008 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 23.10 | 84.90 | 1756 | 1616 | 1.0865 | 1.0394 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 24.81 | 84.90 | 1676 | 1769 | 0.9472 | 0.9754 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 24.81 | 84.90 | 1783 | 1769 | 1.0076 | 1.0035 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 24.81 | 84.90 | 1770 | 1769 | 1.0003 | 1.0001 | MN20160318_Q02 | F06 |